Literature DB >> 8603072

Negative regulation of cell growth by TGF beta.

K Polyak1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8603072     DOI： 10.1016/0304-419x(95)00009-5

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN： 0006-3002


× No keyword cloud information.
  21 in total

1.  Relation between transforming growth factor-β1 expression, its receptor and clinicopathological factors and survival in HER2-negative gastric cancers.

Authors:  Julian Ananiev; Maya Gulubova; Georgi Tchernev; Mariana Penkova; Radostina Miteva; Alexander Julianov; Irena Manolova
Journal:  Wien Klin Wochenschr       Date:  2011-10-24       Impact factor: 1.704

2.  Myc downregulation by transforming growth factor beta required for activation of the p15(Ink4b) G(1) arrest pathway.

Authors:  B J Warner; S W Blain; J Seoane; J Massagué
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

3.  Transforming growth factor beta(1) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1).

Authors:  F Depoortere; I Pirson; J Bartek; J E Dumont; P P Roger
Journal:  Mol Biol Cell       Date:  2000-03       Impact factor: 4.138

4.  Hypo-phosphorylation of the retinoblastoma protein (pRb) by cyclin D:Cdk4/6 complexes results in active pRb.

Authors:  S A Ezhevsky; H Nagahara; A M Vocero-Akbani; D R Gius; M C Wei; S F Dowdy
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

5.  The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2.

Authors:  D L Jones; R M Alani; K Münger
Journal:  Genes Dev       Date:  1997-08-15       Impact factor: 11.361

6.  Inhibition of spermidine synthase gene expression by transforming growth factor-beta 1 in hepatoma cells.

Authors:  Y Nishikawa; S Kar; L Wiest; A E Pegg; B I Carr
Journal:  Biochem J       Date:  1997-01-15       Impact factor: 3.857

7.  Transforming growth factor beta can be a parameter of aggressiveness of pT1 colorectal cancer.

Authors:  Katarzyna Guzinska-Ustymowicz; Andrzej Kemona
Journal:  World J Gastroenterol       Date:  2005-02-28       Impact factor: 5.742

Review 8.  The clinicopathological features of gastric carcinomas with microsatellite instability may be mediated by mutations of different "target genes": a study of the TGFbeta RII, IGFII R, and BAX genes.

Authors:  C Oliveira; R Seruca; M Seixas; M Sobrinho-Simões
Journal:  Am J Pathol       Date:  1998-10       Impact factor: 4.307

9.  Differential expression of cytokine transcripts in human epithelial ovarian carcinoma by solid tumour specimens, peritoneal exudate cells containing tumour, tumour-infiltrating lymphocyte (TIL)-derived T cell lines and established tumour cell lines.

Authors:  M A Nash; R Lenzi; C L Edwards; J J Kavanagh; A P Kudelka; C F Verschraegen; C D Platsoucas; R S Freedman
Journal:  Clin Exp Immunol       Date:  1998-05       Impact factor: 4.330

10.  Expression of transforming growth factor beta in renal cell carcinoma and matched non-involved renal tissue.

Authors:  Dionisios Mitropoulos; Aspasia Kiroudi; Evangelia Christelli; Efraim Serafetinidis; Anastasios Zervas; Ioannis Anastasiou; Constantinos Dimopoulos
Journal:  Urol Res       Date:  2004-09-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.